Not all moderate disease is the same – Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity

BACKGROUND: United Kingdom guidelines for the use of biologic disease modifying anti-rheumatic drugs (bDMARDS) for rheumatoid arthritis (RA) require patients to have active disease (Disease Activity Score [DAS28] >5.1) and have failed ≥2 previous conventional synthetic DMARDs (csDMARD). Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yi, Norton, Sam, Gwinnutt, James M., Kearsley-Fleet, Lianne, Symmons, Deborah P. M., Lunt, Mark, Young, Adam, Hyrich, Kimme L., Verstappen, Suzanne M. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527224/
https://www.ncbi.nlm.nih.gov/pubmed/31107887
http://dx.doi.org/10.1371/journal.pone.0215999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527224/
https://www.ncbi.nlm.nih.gov/pubmed/31107887
http://dx.doi.org/10.1371/journal.pone.0215999

Ejemplares similares